Word

PHASELAB

Status

Registered

Status Code

700

Status Date

Tuesday, April 9, 2024

Serial Number

97623129

Registration Number

7350647

Registration Date

Tuesday, April 9, 2024

Mark Type

3000

Filing Date

Friday, October 7, 2022

Published for Opposition

Tuesday, January 23, 2024

Trademark Owner History

Phase Scientific International Limited - Owner At Publication

Classifications

35 Advertising services; business management, organization and administration; retail store and wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; retail store services featuring medical diagnostic products

44 Medical diagnosis, medical diagnosis of human diseases, namely, genetic, infectious, neurological, cardiovascular, cancerous, inflammatory, reproductive and developmental diseases; medical diagnosis of cancer, ovary cancer, liver cancer, stomach cancer, pancreas cancer, esophagus cancer, colorectum cancer, lung cancer, or breast cancer; medical diagnostic testing, monitoring and reporting services; provision, arranging and conducting of medical, hospital, clinical, surgical beauty care and health care services; hygienic and beauty care services; medical services; medical clinics services and medical analysis services for diagnostic and treatment purpose provided by medical laboratories; dentistry; genetic testing for medical purposes; medical and healthcare consultation; medical, physical rehabilitation, and physical therapy services; COVID-19 detection services; management and operation of medical and dental facilities; consultancy services and preparation of reports in connection with the aforesaid services

42 Consulting services for others in the field of design, planning, and implementation project management of scientific research, analysis, and testing in the field of chemistry, genetics, biology and biochemistry; research services in the field of forensic science, namely, analysis, detection and isolation of biological substances in forensic samples; research and development and consultation related thereto in the field of chemistry, genetics, biology and biochemistry; scientific research and development; chemical, biochemical biological and bacteriological research and analysis; DNA analysis services for scientific research purposes; scientific and technological services, namely, research and design in the field of biology, biomedicine, and biotechnology, molecular diagnostics and molecular medicine; custom design and development of chemical reagents and biochemical assays; clinical research; medical laboratory research, analysis and services; medical and scientific research in the fields of treatment for cancer and oncology, and in the fields of treatment of inflammation and autoimmune diseases

The mark consists of three parallel quadrilaterals divided in half to the left of the word 'PHASELAB".
PHASE LAB
Color is not claimed as a feature of the mark.

Trademark Events

Apr 9, 2024

Registered-Principal Register

Apr 9, 2024

Notice Of Registration Confirmation Emailed

Jan 23, 2024

Official Gazette Publication Confirmation E-Mailed

Jan 23, 2024

Published For Opposition

Jan 3, 2024

Notification Of Notice Of Publication E-Mailed

Dec 18, 2023

Approved For Pub - Principal Register

Dec 18, 2023

Teas/Email Correspondence Entered

Dec 18, 2023

Correspondence Received In Law Office

Oct 30, 2023

Teas Response To Suspension Inquiry Received

Aug 13, 2023

Notification Of Letter Of Suspension E-Mailed

Aug 13, 2023

Letter Of Suspension E-Mailed

Aug 13, 2023

Suspension Letter Written

Aug 10, 2023

Teas/Email Correspondence Entered

Aug 10, 2023

Correspondence Received In Law Office

Aug 10, 2023

Teas Response To Office Action Received

Aug 3, 2023

Notification Of Non-Final Action E-Mailed

Aug 3, 2023

Non-Final Action E-Mailed

Aug 3, 2023

Non-Final Action Written

Jul 23, 2023

Assigned To Examiner

Apr 13, 2023

Teas Voluntary Amendment Received

Oct 25, 2022

Notice Of Design Search Code E-Mailed

Oct 24, 2022

New Application Office Supplied Data Entered

Oct 11, 2022

New Application Entered